(IN BRIEF) Fabentech, a French biopharmaceutical company, has secured a €20 million loan from the European Investment Bank (EIB) through…
(IN BRIEF) AstraZeneca's inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk of severe asthma exacerbations…
(IN BRIEF) AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the…
(IN BRIEF) Fresenius Kabi, in collaboration with Formycon, has received approval from the European Commission (EC) for FYB202, a biosimilar…
(IN BRIEF) Fresenius Kabi, in partnership with Formycon AG, has received European Commission approval for Otulfi®, a biosimilar of ustekinumab.…
(IN BRIEF) SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed the “Alliance for RTU” to promote the adoption of ready-to-use…
(IN BRIEF) Roche has announced positive results from its phase III REGENCY study, showing that its drug Gazyva®/Gazyvaro® (obinutuzumab) significantly…
(IN BRIEF) Krka employees participated in the European Mobility Week for the ninth consecutive year, promoting sustainable commuting through the…
(IN BRIEF) Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA)…
(IN BRIEF) FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US,…